When the causal mutation is known, the challenge shifts from identifying disease origins to defining its detectable beginning ...

Background Ofatumumab and ocrelizumab are widely used high-efficacy anti-CD20 therapies for relapsing-remitting multiple ...

Register studies (Wimberly et al ) reveal the long-lasting educational disadvantage of childhood epilepsy but unexpected sex ...

Background Published cases of iatrogenic cerebral amyloid angiopathy (iCAA) are increasing; however, their geographic ...

Background Autosomal dominant Alzheimer’s disease (ADAD) serves as a model for presymptomatic biomarker discovery.

Background Information about the incidence of cerebral cavernous malformations (CCM) is sparse and the effect of increasing MRI availability is uncertain. Our objective was to assess the incidence of ...

Functional neurological disorder (FND) is a common and disabling disorder that is often considered difficult to treat, particularly in adults. Psychological therapies are often recommended for FND.

Background The role of physical activity in the risk of amyotrophic lateral sclerosis (ALS) is debated. It is also unclear whether the association differs in people at high genetic risk of ALS.

Background Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, is a high-efficacy therapy for multiple sclerosis (MS). Methods Patients with relapse-onset MS treated with ocrelizumab, ...

Stroke Unit, Department of Neuroscience, University of Perugia, Perugia, Italy Correspondence to: Dr Maurizio Paciaroni Department of Neuroscience, University of Perugia, Via Enrico dal Pozzo, 06126 ...

Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Dr D E Newman-Toker, Department of Neurology, The Johns Hopkins Hospital, ...

Dr Neil Anderson, Department of Medicine, University of Auckland, Private Bag 92019, Auckland 1, New Zealand. OBJECTIVES The frequency and characteristics of the long term sequelae of herpes simplex ...